Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avricore HealthTSXV:AVCR Days Inventory is 67.15 as of Mar. 2026, which is 63% below its 10-year median of 182.90. The stock has 6 warning signs investors should review. Among 178 Medical Diagnostics & Research companies, Avricore Health ranks better than 86.52% on this metric.
The historical rank and industry rank for Avricore Health's Days Inventory or its related term are showing as below:
TSXV:AVCR'
s Days Inventory Range Over the Past 10 Years
Min: 1.23 Med: 182.9 Max: 3570.16
Current: 18.18
During the past 13 years, Avricore Health's highest Days Inventory was 3570.16. The lowest was 1.23. And the median was 182.90.
TSXV:AVCR's Days Inventory is ranked better than 86.52% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.86
vs TSXV:AVCR: 18.18
Avricore Health's Days Inventory
increased
from Mar. 2025 (2.59) to Mar. 2026 (67.15).
It might indicate that Avricore Health's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Avricore Health's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avricore Health's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.89.
Avricore Health (TSXV:AVCR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Avricore Health's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avricore Health's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Avricore Health Days Inventory Related Terms
Avricore Health Days Inventory Historical Data
* Premium members only.
The historical data trend for Avricore Health's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:AVCR vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Avricore Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avricore Health Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Days Inventory distribution charts can be found below:
* The bar in red indicates where Avricore Health's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avricore Health (TSXV:AVCR) has a Days Inventory of 67.15 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avricore Health and its competitors. This is 63% below median its historical median of 182.90. Over the past decade, Avricore Health's Days Inventory has ranged from 1.23 to 3,570.16. According to the industry distribution chart, Avricore Health ranks #24 out of 178 companies in the Medical Diagnostics & Research industry, placing it in the top 13.5%.
Is Avricore Health's Days Inventory too high?
Avricore Health's current Days Inventory of 67.15 is 63% below median its 10-year median of 182.90. Over the past 10 years, this metric has ranged from a low of 1.23 to a high of 3,570.16. The Medical Diagnostics & Research industry median Days Inventory is 64.86. Avricore Health's value of 67.15 is 3.5% above this industry median. Based on the distribution chart, Avricore Health ranks #24 out of 178 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Avricore Health's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Avricore Health ranks #24 out of 178 companies for Days Inventory. This places Avricore Health in the top 14% of its industry — outperforming the majority of peers. The industry median Days Inventory is 64.86. Avricore Health's value of 67.15 is 3.5% above this benchmark. Historically, Avricore Health's own Days Inventory has ranged from 1.23 to 3,570.16 over the past decade. While the company's 10-year median is 182.90 vs. the industry median of 64.86, Avricore Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 64.86, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avricore Health's current Days Inventory of 67.15 is 3.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avricore Health and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 64.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avricore Health's current Days Inventory is 67.15, which is 63% below median its own 10-year median of 182.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avricore Health stock overvalued right now?
Based on GuruFocus' analysis, Avricore Health (TSXV:AVCR) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.02, compared to a current price of C$0.05 — trading 150% above its estimated fair value. The current Days Inventory is 67.15, which is 63% below median its 10-year median of 182.90 and 3.5% above the Medical Diagnostics & Research industry median of 64.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Avricore Health (TSXV:AVCR), the current Days Inventory is 67.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:AVCR has been successfully added to your 
